Shares of Doximity (NYSE: DOCS) rocketed 35% higher as of 1:45 p.m. ET Friday, according to data provided by S&P Global ...

Doximity's fiscal 2025 Q2 earnings beat analyst and management expectations despite ongoing macroeconomic uncertainties in ...

The online medical platform reported quarterly revenue of $136.8 million and earnings of 30 cents a share, beating analysts ...

Morgan Stanley has upgraded Doximity (DOCS) to equal weight from underweight, citing renewed momentum in its business and conservative Q4 guidance. Read more here.

In a report released today, Jailendra Singh from Truist Financial assigned a Hold rating to Doximity (DOCS – Research Report). The ...

Morgan Stanley analyst Craig Hettenbach upgraded Doximity (DOCS) to Equal Weight from Underweight with a price target of $53, up from $33.

Canaccord Genuity on Wednesday downgraded Doximity (NYSE:DOCS) to hold from buy, noting that its shares, after a more than 30% rally following the company’s Q2 results, already reflect high ...

In the runner up spot for lowest paid medical specialty is pediatrics at $259,579. Pediatricians provide care for babies, ...

Pavlo Gonchar / SOPA Images / LightRocket / Getty Images Doximity shares surged Friday morning after the company's second quarter results and outlook for the rest of its fiscal year beat estimates.

The round saw participation from Perplexity CTO Denis Yarats, Kleiner Perkins Scout Fund, Y Combinator, Snorkel AI CEO Alex ...

In the last three months, 9 analysts have published ratings on Doximity DOCS, offering a diverse range of perspectives from ...

Doximity, Inc. (NASDAQ:DOCS – Get Free Report) shares reached a new 52-week high on Friday . The company traded as high as $57.10 and last traded at $57.10, with a volume of 272953 shares trading ...